Mach37, the CIT-backed accelerator for cybersecurity startups, has announced its spring cohort of investments. The companies include services ranging from…
Symbiomix Therapeutics, a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women's health infections, today announced results from…